NTHI — NEONC TECHNOLOGIES HOLDINGS, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1979414 ·
Last close
$3.49
Market Cap
$90.50M
52W High
$6.84
52W Low
$3.01
ADV30
77,993
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -7,008,539 | -8,819,932 | 3,330,161 | 138,601 | 16,561,326 |
| Dec 2025 | 0 | — | -13,625,675 | -15,524,104 | 2,823,634 | 58,729 | 20,331,363 |
| Sep 2025 | 0 | — | -6,934,647 | -8,615,920 | 4,082,916 | 1,513,224 | 15,897,186 |
| Jun 2025 | 0 | — | -5,708,034 | -5,680,170 | 2,988,187 | 125,039 | 14,803,681 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-21,705,667
Investing CF
—
Financing CF
$16,905,056
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.91
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-121,574,587
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-35,461,857
Pretax Income TTM
$-38,640,126
Interest Exp TTM
$3,178,269
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$0
EBITDA
—
Free Cash Flow
$-1,603,043
Enterprise Value
$88,560,872
Total Cash
$138,601
Total Debt
$346,053
Shares Out
25,931,865
Trailing EPS
$-1.80
Book Value
$-0.55
ROE
—
ROA
-354.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 39,990 | -58,169,198 | -62,146,210 | 2,823,634 | 20,331,363 | — | -20,363,948 |
| Dec 2024 | 83,000 | -7,142,522 | -11,898,464 | 3,417,241 | 8,922,202 | — | -4,213,916 |
| Dec 2023 | 70,462 | -8,097,669 | -14,921,065 | 1,265,376 | 15,253,629 | — | -1,880,012 |
| Dec 2022 | 20,000 | -2,837,604 | -3,046,757 | 728,682 | 2,304,093 | — | -881,736 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.75
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc. | $89.67M | $5.22 | — |
| ONCY | ONCOLYTICS BIOTECH INC | $89.52M | $0.75 | — |
| ZOMDF | Zomedica Corp. | $88.20M | $0.09 | — |
| ALDX | Aldeyra Therapeutics, Inc. | $92.89M | $1.54 | — |
| RANI | Rani Therapeutics Holdings, Inc. | $86.99M | $0.77 | — |
News headlines (Yahoo Finance, 1h cache)
NeOnc Technologies Appoints Strategy and Finance Executive Nasim Shomali to its Board of Directors
2026-07-27 14:37 · Yahoo
NeOnc Receives FDA Written Feedback on NEO212 CMC Development and Capsule-to-Tablet Transition
2026-07-15 13:25 · Yahoo
NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone
2026-06-23 14:56 · Yahoo
WSTPR Catalyst Watch: Abu Dhabi Regulatory Clearance Adds Momentum to NeOnc's Global Neuro-Oncology Strategy
2026-06-22 12:45 · Yahoo
NeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development
2026-06-16 14:03 · Yahoo
WSTPR Catalyst Watch: NeOnc Strengthens Capital Position Ahead of Potentially Transformational Neuro-Oncology Updates
2026-06-15 12:35 · Yahoo
The Race to Defeat Brain Cancer Could Become One of the Biggest Biotech Stories of the Decade
2026-06-09 12:45 · Yahoo
NeOnc Technologies (NTHI) Could Be Targeting A Challenging Market With A Different Strategy
2026-05-31 14:38 · Yahoo
NeOnc Provides Business Update and Reports Q1 2026 Financial Results
2026-05-18 13:00 · Yahoo
Forget the 242% Biotech Meme. This Brain Cancer Stock Has a $38 Analyst Target and Trades at $6
2026-05-14 15:39 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.